telavancin
(ONUMZHGUFYIKPM-MXNFEBESSA-N)
Structure
- SMILES
- CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@H]2[C@@H](O[C@@H]([C@H]([C@@H]2O)O)CO)Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(=O)N)NC(=O)[C@@H]([C@@H](c4ccc(O3)c(Cl)c4)O)NC(=O)[C@@H](CC(C)C)NC)c3ccc(c(c3)c3c([C@H](NC2=O)C(=O)O)cc(c(c3O)CNCP(=O)(O)O)O)O)O[C@H]([C@H]1O)C
- Type(s)
- Approved
- ATC code(s)
- J01XA03
- Molecular Formula:
- C80H106Cl2N11O27P
- Molecular Weight:
- 1755.630
- Log P:
- 6.9910
- Hydrogen Bond Acceptor:
- 38
- Hydrogen Bond Donor:
- 23
- TPSA:
- 607.9
- CAS Number(s):
- 372151-71-8
Synonym(s)
1.
telavancin
2.
TD 6424
3.
TD-6424
4.
TD6424
5.
Vibativ
6.
telavancin hydrochloride
External Link(s)
Adverse Drug Event(s)
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.